1. Home
  2. MMM vs SNY Comparison

MMM vs SNY Comparison

Compare MMM & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 3M Company

MMM

3M Company

N/A

Current Price

$158.10

Market Cap

81.8B

Sector

Health Care

ML Signal

N/A

Logo Sanofi ADS

SNY

Sanofi ADS

N/A

Current Price

$46.74

Market Cap

119.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MMM
SNY
Founded
1902
1994
Country
United States
France
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
81.8B
119.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MMM
SNY
Price
$158.10
$46.74
Analyst Decision
Buy
Buy
Analyst Count
9
6
Target Price
$174.78
$61.50
AVG Volume (30 Days)
3.2M
2.8M
Earning Date
01-20-2026
01-29-2026
Dividend Yield
1.87%
3.46%
EPS Growth
N/A
105.93
EPS
6.00
8.67
Revenue
$24,948,000,000.00
$53,890,648,839.00
Revenue This Year
$1.42
$1.73
Revenue Next Year
$3.01
$6.49
P/E Ratio
$25.98
$5.33
Revenue Growth
1.52
N/A
52 Week Low
$121.98
$44.62
52 Week High
$174.69
$60.12

Technical Indicators

Market Signals
Indicator
MMM
SNY
Relative Strength Index (RSI) 40.08 41.54
Support Level $153.07 $45.25
Resistance Level $173.06 $48.17
Average True Range (ATR) 4.11 0.73
MACD -0.84 -0.15
Stochastic Oscillator 25.21 34.35

Price Performance

Historical Comparison
MMM
SNY

About MMM 3M Company

3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: